ProfileGDS4718 / 217884_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 81% 82% 83% 79% 93% 95% 86% 77% 84% 85% 79% 92% 94% 92% 86% 81% 94% 94% 87% 84% 83% 81% 83% 86% 93% 80% 94% 83% 95% 86% 91% 76% 79% 93% 91% 94% 87% 83% 82% 81% 94% 88% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.654186
GSM549102patient 115, normal, homogenized [OPG study]7.8914281
GSM549104patient 119, normal, homogenized [OPG study]8.1758882
GSM549108patient 138, normal, homogenized [OPG study]8.1528383
GSM549119patient 077, normal, homogenized [OPG study]7.6338779
GSM549133patient 032, cancer, homogenized [OPG study]9.803793
GSM549139patient 042, cancer, homogenized [OPG study]10.267795
GSM549099patient 107, normal, homogenized [OPG study]8.4923186
GSM549109patient 139, normal, homogenized [OPG study]7.523177
GSM549110patient 046, normal, homogenized [OPG study]8.2737284
GSM549114patient 063, normal, homogenized [OPG study]8.5655385
GSM549122patient 082, normal, homogenized [OPG study]7.7098779
GSM549134patient 033, cancer, homogenized [OPG study]9.5745792
GSM549136patient 036, cancer, homogenized [OPG study]10.039894
GSM549140patient 044, cancer, homogenized [OPG study]9.5063892
GSM549111patient 047, normal, homogenized [OPG study]8.6718886
GSM549113patient 057, normal, homogenized [OPG study]8.0322781
GSM549132patient 031, cancer, homogenized [OPG study]9.8050794
GSM549137patient 038, cancer, homogenized [OPG study]9.8100294
GSM549142patient 047, cancer, homogenized [OPG study]8.2717387
GSM549100patient 110, normal, homogenized [OPG study]8.3243584
GSM549107patient 135, normal, homogenized [OPG study]8.27483
GSM549115patient 068, normal, homogenized [OPG study]8.0633681
GSM549116patient 072, normal, homogenized [OPG study]8.2398983
GSM549120patient 078, normal, homogenized [OPG study]8.6413386
GSM549131patient 030, cancer, homogenized [OPG study]9.6940393
GSM549118patient 074, normal, homogenized [OPG study]7.8833280
GSM549129patient 027, cancer, homogenized [OPG study]9.7530294
GSM549123patient 088, normal, homogenized [OPG study]8.2584283
GSM549124patient 006, cancer, homogenized [OPG study]9.9991195
GSM549126patient 015, cancer, homogenized [OPG study]8.5205386
GSM549128patient 025, cancer, homogenized [OPG study]9.3325991
GSM549103patient 117, normal, homogenized [OPG study]7.3563976
GSM549117patient 073, normal, homogenized [OPG study]7.7908179
GSM549138patient 041, cancer, homogenized [OPG study]9.736193
GSM549141patient 045, cancer, homogenized [OPG study]9.4299291
GSM549130patient 028, cancer, homogenized [OPG study]9.7731194
GSM549101patient 111, normal, homogenized [OPG study]8.6297987
GSM549105patient 128, normal, homogenized [OPG study]8.2165683
GSM549106patient 134, normal, homogenized [OPG study]8.2558582
GSM549112patient 048, normal, homogenized [OPG study]8.0233881
GSM549125patient 011, cancer, homogenized [OPG study]9.8007394
GSM549127patient 024, cancer, homogenized [OPG study]8.8263288
GSM549135patient 035, cancer, homogenized [OPG study]10.16195